22 May 2017

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology today announces that an application has been made to the London Stock Exchange to extend its block listings of securities in respect of a total of 3,360,000 ordinary shares of 0.2 pence each (the "Ordinary Shares") which may arise pursuant to the exercise of options under its Unapproved Share Option Scheme ("USOS") and its EMI Share Option Scheme ("EMI").

Admission of the above additional shares to be block listed is expected to occur on or around 25 May 2017.

The Company makes the following update on its block listings, pursuant to AIM Rule 29 and Schedule Six of the AIM Rules for Companies. All figures relate to options over Ordinary Shares.

The table below provides further detail:

Name of company: Futura Medical plc    
Name of scheme(s): USOS
EMI
   
Period of return: From: 25 November 2016    
To: 22 May 2017    
Number and class of securities not issued under the scheme(s) at beginning of period USOS: 1,156,321    
EMI: 1,364,141    
Total: 2,520,462    
Number and class of securities admitted to the scheme(s) in the period USOS: 1,466,208    
EMI: 1,893,792    
Total: 3,360,000    
Number of securities issued under the scheme(s) during the period

Number of securities lapsed under the scheme(s) during the period
USOS: (176,419)    
EMI:
USOS:
EMI:
(236,543)
-
-
   
Balance of securities under the scheme(s) not yet issued at the end of the period USOS: 2,446,110    
EMI: 3,021,390    
Total: 5,467,500    
         
Number and class of securities originally admitted and the date of admission USOS: 814,424 on 25 May 2011, 1,202,280 on 8 October 2013,
1,466,208 on 25 May 2017
USOS Total: 3,482,912      
         
EMI: 1,520,576 on 25 May 2011, 1,467,720 on 8 October 2013,
1,893,792 on 25 May 2017
EMI Total: 4,882,088      
         
  Total: 8,365,000
     
Name of contact: Derek Martin, Chief Financial Officer
Telephone number of contact: +44 (0) 1483 685 670

 

For further information please contact:

Futura Medical plc
James Barder, Chief Executive
+44 (0) 1483 685 670
james.barder@futuramedical.com
www.futuramedical.com

Nominated Adviser:
N+1 Singer
Aubrey Powell / Liz Yong / Thomas Smale
Tel: +44 (0) 20 7496 3000

For media enquiries please contact:

Buchanan Communications Limited
Mark Court / Sophie Cowles /
Stephanie Watson
Tel: +44 (0) 20 7466 5000

 

Notes to editors:

About Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com